Identifying the preferable rheumatoid arthritis subgroups for intervention with the anti-RANKL antibody denosumab to reduce progression of joint destruction

Yoshiya Tanaka; Satoshi Soen; Naoki Ishiguro; Hisashi Yamanaka; Toshiyuki Yoneda; Sakae Tanaka; Takeshi Ohira; Takaya Nitta; Naoki Okubo; Harry Genant; Desirée van der Heijde; Tsutomu Takeuchi

doi:10.1136/rmdopen-2020-001249

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest Content

Archive

For authors

About

Podcasts
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Citation Tools

PDF

XML

Rheumatoid arthritis

Original research

Identifying the preferable rheumatoid arthritis subgroups for intervention with the anti-RANKL antibody denosumab to reduce progression of joint destruction

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:: Tanaka Y, Soen S, Ishiguro N, et al

Identifying the preferable rheumatoid arthritis subgroups for intervention with the anti-RANKL antibody denosumab to reduce progression of joint destruction

RMD Open 2020;6:e001249. doi: 10.1136/rmdopen-2020-001249

Log in using your username and password

Main menu

Log in using your username and password

You are here

Download to a citation manager

Read the full text or download the PDF:

Log in using your username and password